23 related articles for article (PubMed ID: 32200877)
1. Factors Affecting Recurrence and Survival for Patients with High-Risk Stage II Melanoma.
Dedeilia A; Lwin T; Li S; Tarantino G; Tunsiricharoengul S; Lawless A; Sharova T; Liu D; Boland GM; Cohen S
Ann Surg Oncol; 2024 Apr; 31(4):2713-2726. PubMed ID: 38158497
[TBL] [Abstract][Full Text] [Related]
2. E-Cadherin Immunostaining in Equine Melanocytic Tumors.
Pimenta J; Pires I; Prada J; Cotovio M
Animals (Basel); 2023 Jul; 13(13):. PubMed ID: 37444014
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological attenuation of melanoma by tryptanthrin pertains to the suppression of MITF-M through MEK/ERK signaling axis.
Shabna A; Antony J; Vijayakurup V; Saikia M; Liju VB; Retnakumari AP; Amrutha NA; Alex VV; Swetha M; Aiswarya SU; Jannet S; Unni US; Sundaram S; Sherin DR; Anto NP; Bava SV; Chittalakkottu S; Ran S; Anto RJ
Cell Mol Life Sci; 2022 Aug; 79(9):478. PubMed ID: 35948813
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic Switching of B16F10 Melanoma Cells as a Stress Adaptation Response to Fe3O4/Salicylic Acid Nanoparticle Therapy.
Mîndrilă I; Osman A; Mîndrilă B; Predoi MC; Mihaiescu DE; Buteică SA
Pharmaceuticals (Basel); 2021 Sep; 14(10):. PubMed ID: 34681232
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Melanoma Extravasation as a New Treatment Option Exemplified by p38/MK2 Inhibition.
Petzelbauer P
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172202
[TBL] [Abstract][Full Text] [Related]
6. Genetic progression of metastatic melanoma.
Rodolfo M; Daniotti M; Vallacchi V
Cancer Lett; 2004 Oct; 214(2):133-47. PubMed ID: 15363539
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of p38/MK2 Signaling Prevents Vascular Invasion of Melanoma.
Wenzina J; Holzner S; Puujalka E; Cheng PF; Forsthuber A; Neumüller K; Schossleitner K; Lichtenberger BM; Levesque MP; Petzelbauer P
J Invest Dermatol; 2020 Apr; 140(4):878-890.e5. PubMed ID: 31622599
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma.
Venza M; Visalli M; Catalano T; Biondo C; Beninati C; Teti D; Venza I
Oncol Rep; 2016 Apr; 35(4):2451-60. PubMed ID: 26883095
[TBL] [Abstract][Full Text] [Related]
9. GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells.
Perrot CY; Gilbert C; Marsaud V; Postigo A; Javelaud D; Mauviel A
Pigment Cell Melanoma Res; 2013 Nov; 26(6):861-73. PubMed ID: 23890107
[TBL] [Abstract][Full Text] [Related]
10. BRAF and epithelial-mesenchymal transition in primary cutaneous melanoma: a role for Snail and E-cadherin?
Mitchell B; Leone DA; Feller JK; Yang S; Mahalingam M
Hum Pathol; 2016 Jun; 52():19-27. PubMed ID: 26980024
[TBL] [Abstract][Full Text] [Related]
11. Notch4 Signaling Induces a Mesenchymal-Epithelial-like Transition in Melanoma Cells to Suppress Malignant Behaviors.
Bonyadi Rad E; Hammerlindl H; Wels C; Popper U; Ravindran Menon D; Breiteneder H; Kitzwoegerer M; Hafner C; Herlyn M; Bergler H; Schaider H
Cancer Res; 2016 Apr; 76(7):1690-7. PubMed ID: 26801977
[TBL] [Abstract][Full Text] [Related]
12. Cellular Phenotypic Plasticity of Cutaneous Melanoma: A Complex Puzzle.
Joshi SS; Hornyak TJ
J Invest Dermatol; 2020 Apr; 140(4):743-745. PubMed ID: 32200877
[TBL] [Abstract][Full Text] [Related]
13. Interplay between small and long non-coding RNAs in cutaneous melanoma: a complex jigsaw puzzle with missing pieces.
Riefolo M; Porcellini E; Dika E; Broseghini E; Ferracin M
Mol Oncol; 2019 Jan; 13(1):74-98. PubMed ID: 30499222
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
